Product Information

OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.1567 per ML under NDC 72205006078. Its NADAC has been published 195 times since Mar 1, 2023.

FDA first approved this application on May 2, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OSELTAMIVIR 6 MG/ML SUSPENSION

oseltamivir phosphate
$0.1567per ML

Strength

6 mg/mL

NDC

72205006078

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OSELTAMIVIR PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215313

FDA Approved

5/2/2022

TE Code

AB

On Market Since

5/6/2022

Pharmacological Classes

Neuraminidase Inhibitor
Neuraminidase Inhibitors

Price Statistics

The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 195 times since Mar 1, 2023, and over the history we have for it it has declined 58.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1567 per ML
All-time high$0.4296 (Aug 16, 2023)
All-time low$0.1271 (Nov 20, 2024)
52-week high$0.1711
52-week low$0.1496
Median price$0.1969
Average price$0.2153
Largest weekly change-56.9% (Sep 20, 2023)
Weeks tracked195
Tracking sinceMar 1, 2023

Price History

1W

+0.8%

1M

+4.7%

3M

+3.7%

6M

-0.5%

1Y

-8.4%

3Y

-38.9%

5Y

N/A

All

-58.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the oseltamivir phosphate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Novadoz Pharmaceuticals LLC, is $0.1567 per ML (NDC 72205006078), effective Nov 18, 2026.

How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?

Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 58.3%. It has been tracked across 195 weekly CMS publications since Mar 1, 2023.

What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?

Since Mar 1, 2023, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $0.4296 (Aug 16, 2023), with a median of $0.1969 per ML.

Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?

No other NADAC-published product currently shares the active ingredient and strength of OSELTAMIVIR 6 MG/ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?

OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 72205006078) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.